UBS Group
AIFF

UBS Group’s Firefly Neuroscience AIFF Stock Holding History

UBS Group’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.5K Sell
59,119
-73,076
-55% -$127K ﹤0.01% 7372
2026
Q1 		$288K Buy
132,195
+107,490
+435% +$134K ﹤0.01% 6423
2025
Q4 		$21.6K Sell
24,705
-66,015
-73% -$123K ﹤0.01% 7727
2025
Q3 		$264K Sell
90,720
-149,668
-62% -$424K ﹤0.01% 6508
2025
Q2 		$680K Buy
240,388
+146,759
+157% +$465K ﹤0.01% 5761
2025
Q1 		$368K Buy
93,629
+77,157
+468% +$355K ﹤0.01% 6095
2024
Q4 		$43.7K Buy
+16,472
New +$51.1K ﹤0.01% 7387
2024
Q3 		– Sell
-2,308
Closed -$14.3K – 10217
2024
Q2 		$14.3K Buy
2,308
+1,293
+127% +$9.62K ﹤0.01% 7519
2024
Q1 		$10.5K Sell
1,015
-1,197
-54% -$8.03K ﹤0.01% 7223
2023
Q4 		$11.2K Buy
2,212
+1,942
+719% +$12.6K ﹤0.01% 7402
2023
Q3 		$2.1K Buy
+270
New +$2.77K ﹤0.01% 7769
2023
Q2 		– Hold
0
– – – 9790
2023
Q1 		– Sell
-625
Closed -$8.99K – 10541
2022
Q4 		$8.99K Buy
625
+150
+32% +$3.49K ﹤0.01% 8702
2022
Q3 		$14K Buy
475
+259
+120% +$9.5K ﹤0.01% 7937
2022
Q2 		$8K Buy
216
+203
+1,562% +$19.6K ﹤0.01% 8370
2022
Q1 		$2K Sell
13
-9
-41% -$1.22K ﹤0.01% 9686
2021
Q4 		$3K Buy
+22
New +$2.63K ﹤0.01% 9703

Other funds holding AIFF

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Cygnus Capital Advisors Atlanta, Georgia $147M AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group's AIFF Position: Q2 2026 in Review

UBS Group reduced its Firefly Neuroscience (AIFF) stake by 55% in Q2 2026, selling an estimated $127K and leaving 59,119 shares worth $71.5K. The position accounts for ﹤0.01% of the portfolio, ranked #7372.

UBS Group first reported a position in AIFF in Q4 2021 and has held it in 16 quarters since. The position peaked at $680K in Q2 2025. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • UBS Group held 59,119 shares of Firefly Neuroscience worth $71.5K as of Q2 2026.
  • UBS Group sold 73,076 Firefly Neuroscience shares in Q2 2026, an estimated $127K.
  • Firefly Neuroscience made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7372 holding.
  • UBS Group first reported a position in Firefly Neuroscience in Q4 2021 and has held it in 16 quarters since.
  • UBS Group's Firefly Neuroscience position peaked at $680K in Q2 2025.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.